George D. Yancopoulos

Person

Yorktown Heights, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
High affinity human antibodies to human IL-4 receptor
- Patent number 12,162,943
- Issue date Dec 10, 2024
- REGENERON PHARMACEUTICALS, INC.
- Joel H. Martin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized M-CSF mice
- Patent number 12,127,536
- Issue date Oct 29, 2024
- REGENERON PHARMACEUTICALS, INC.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Genetically modified non-human animals and methods of use thereof
- Patent number 12,127,537
- Issue date Oct 29, 2024
- REGENERON PHARMACEUTICALS, INC.
- Richard Flavell
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Targeted modification of rat genome
- Patent number 12,037,596
- Issue date Jul 16, 2024
- REGENERON PHARMACEUTICALS, INC.
- Jeffrey D. Lee
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of a VEGF antagonist to treat angiogenic eye disorders
- Patent number 11,986,511
- Issue date May 21, 2024
- REGENERON PHARMACEUTICALS, INC.
- George D. Yancopoulos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of a VEGF antagonist to treat angiogenic eye disorders
- Patent number 11,975,045
- Issue date May 7, 2024
- REGENERON PHARMACEUTICALS, INC.
- George Yancopoulos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination of IL-4/IL-13 pathway inhibitors and plasma cell ablati...
- Patent number 11,964,016
- Issue date Apr 23, 2024
- REGENERON PHARMACEUTICALS, INC.
- Seblewongel Asrat
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
EGFR × CD28 multispecific antibodies
- Patent number 11,912,767
- Issue date Feb 27, 2024
- REGENERON PHARMACEUTICALS, INC.
- Dimitris Skokos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating inflammatory conditions of the airway or lungs...
- Patent number 11,866,503
- Issue date Jan 9, 2024
- REGENERON PHARMACEUTICALS, INC.
- Jamie M. Orengo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for the targeted modification of a genome
- Patent number 11,820,997
- Issue date Nov 21, 2023
- REGENERON PHARMACEUTICALS, INC.
- David Frendewey
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Genetically modified non-human animals and methods of use thereof
- Patent number 11,778,995
- Issue date Oct 10, 2023
- REGENERON PHARMACEUTICALS, INC.
- Richard Flavell
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Grant
Use of a VEGF antagonist to treat angiogenic eye disorders
- Patent number 11,730,794
- Issue date Aug 22, 2023
- REGENERON PHARMACEUTICALS, INC.
- George Yancopoulos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding f...
- Patent number 11,732,030
- Issue date Aug 22, 2023
- REGENERON PHARMACEUTICALS, INC.
- Robert Babb
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of a VEGF antagonist to treat angiogenic eye disorders
- Patent number 11,707,506
- Issue date Jul 25, 2023
- Regeneren Pharmaceuticals, Inc.
- George Yancopoulos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for targeted genetic modification using pa...
- Patent number 11,697,828
- Issue date Jul 11, 2023
- Regeneran Pharmaceuticals, Inc.
- David Frendewey
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Genetically modified non-human animals and methods of use thereof
- Patent number 11,576,356
- Issue date Feb 14, 2023
- REGENERON PHARMACEUTICALS, INC.
- Dietmar Herndler-Brandstetter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of a VEGF antagonist to treat angiogenic eye disorders
- Patent number 11,559,564
- Issue date Jan 24, 2023
- REGENERON PHARMACEUTICALS, INC.
- George D. Yancopoulos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific anti-PSMA X anti-CD28 antibodies and uses thereof
- Patent number 11,548,947
- Issue date Jan 10, 2023
- REGENERON PHARMACEUTICALS, INC.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereof
- Patent number 11,453,721
- Issue date Sep 27, 2022
- Regeneran Pharmaceuticals, Inc.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific anti-CD28 × anti-CD22 antibodies and uses thereof
- Patent number 11,396,544
- Issue date Jul 26, 2022
- REGENERON PHARMACEUTICALS, INC.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating an allergy with allergen-specific monoclonal ant...
- Patent number 11,352,417
- Issue date Jun 7, 2022
- REGENERON PHARMACEUTICALS, INC.
- Jamie M. Orengo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of a VEGF antagonist to treat angiogenic eye disorders
- Patent number 11,253,572
- Issue date Feb 22, 2022
- REGENERON PHARMACEUTICALS, INC.
- George Yancopoulos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Genetically modified mice and engraftment
- Patent number 11,051,499
- Issue date Jul 6, 2021
- REGENERON PHARMACEUTICALS, INC.
- Sean Stevens
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Grant
Genetically modified non-human animals and methods of use thereof
- Patent number 11,026,408
- Issue date Jun 8, 2021
- REGENERON PHARMACEUTICALS, INC.
- Richard Flavell
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Grant
Methods of modifying genes in eukaryotic cells
- Patent number 10,988,776
- Issue date Apr 27, 2021
- REGENERON PHARMACEUTICALS, INC.
- Aris N. Economides
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Targeted modification of rat genome
- Patent number 10,975,390
- Issue date Apr 13, 2021
- REGENERON PHARMACEUTICALS, INC.
- Jeffrey D. Lee
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding f...
- Patent number 10,975,139
- Issue date Apr 13, 2021
- REGENERON PHARMACEUTICALS, INC.
- Robert Babb
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding f...
- Patent number 10,954,289
- Issue date Mar 23, 2021
- Regeneren Pharmaceuticals, Inc.
- Robert Babb
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Diagnostic tests and methods for assessing safety, efficacy or outc...
- Patent number 10,935,554
- Issue date Mar 2, 2021
- REGENERON PHARMACEUTICALS, INC.
- George D. Yancopoulos
- G01 - MEASURING TESTING
Information Patent Grant
Use of a VEGF antagonist to treat angiogenic eye disorders
- Patent number 10,888,601
- Issue date Jan 12, 2021
- REGENERON PHARMACEUTICALS, INC.
- George D. Yancopoulos
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODY RESISTANT MODIFIED RECEPTORS TO ENHANCE CELL-BASED THERAPIES
- Publication number 20240390460
- Publication date Nov 28, 2024
- Regeneron Pharmaceuticals, Inc.
- Michael Moore
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION OF IL-4/IL-13 PATHWAY INHIBITORS AND PLASMA CELL ABALAT...
- Publication number 20240350625
- Publication date Oct 24, 2024
- Regeneron Pharmaceuticals, Inc.
- Seblewongel ASRAT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR OBTAINING ANTIBODY MOLECULES WITH HIGH AFFINITY
- Publication number 20240345083
- Publication date Oct 17, 2024
- Regeneron Pharmaceuticals, Inc.
- Wen-Yi Lee
- G01 - MEASURING TESTING
Information Patent Application
METHODS AND COMPOSITIONS FOR INSERTION OF ANTIBODY CODING SEQUENCES...
- Publication number 20240301442
- Publication date Sep 12, 2024
- Regeneron Pharmaceuticals, Inc.
- Cheng Wang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
T CELL ACTIVATORS AND METHODS OF USE THEREOF
- Publication number 20240287186
- Publication date Aug 29, 2024
- Regeneron Pharmaceuticals, Inc.
- Aarthi PUTARJUNAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INDUCED NK CELLS RESPONSIVE TO CD3/TAA BISPECIFIC ANTIBODIES
- Publication number 20240277844
- Publication date Aug 22, 2024
- Regeneron Pharmaceuticals, Inc.
- Nicolin Bloch
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF TREATING INFLAMMATORY CONDITIONS
- Publication number 20240209102
- Publication date Jun 27, 2024
- Regeneron Pharmaceuticals, Inc.
- Jamie M. ORENGO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-C5 ANTIBODY/C5 IRNA CO-FORMULATIONS AND COMBINATION THERAPIES
- Publication number 20240175027
- Publication date May 30, 2024
- Regeneron Pharmaceuticals, Inc.
- Mary Kleppe
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Treatment Of Kidney Diseases With A Combination of Angiopoietin Lik...
- Publication number 20240158795
- Publication date May 16, 2024
- Regeneron Pharmaceuticals, Inc.
- Mary E. Haas
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Use of a VEGF Antagonist to Treat Angiogenic Eye Disorders
- Publication number 20240123030
- Publication date Apr 18, 2024
- Regeneron Pharmaceuticals, Inc.
- George D. YANCOPOULOS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS OF USE THEREOF
- Publication number 20240099278
- Publication date Mar 28, 2024
- Regeneron Pharmaceuticals, Inc.
- Richard Flavell
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
METHODS AND COMPOSITIONS FOR THE TARGETED MODIFICATION OF A GENOME
- Publication number 20240052365
- Publication date Feb 15, 2024
- Regeneron Pharmaceuticals, Inc.
- David Frendewey
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Anti-SARS-CoV-2-Spike Glycoprotein Antibodies and Antigen-Binding F...
- Publication number 20240043504
- Publication date Feb 8, 2024
- Regeneron Pharmaceuticals, Inc.
- Alina Baum
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Anti-SARS-CoV-2-Spike Glycoprotein Antibodies and Antigen-Binding F...
- Publication number 20230348569
- Publication date Nov 2, 2023
- Regeneron Pharmaceuticals, Inc.
- Robert Babb
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR TARGETED GENETIC MODIFICATION USING PA...
- Publication number 20230332185
- Publication date Oct 19, 2023
- Regeneron Pharmaceuticals, Inc.
- David Frendewey
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
EGFR x CD28 MULTISPECIFIC ANTIBODIES
- Publication number 20230322927
- Publication date Oct 12, 2023
- Regeneron Pharmaceuticals, Inc.
- Dimitris Skokos
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-ACTIVIN A ANTIBODIES AND USES THEREOF
- Publication number 20230312699
- Publication date Oct 5, 2023
- Regeneron Pharmaceuticals, Inc.
- Jesper Gromada
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bispecific Anti-PSMA x Anti-CD28 Antibodies and Uses Thereof
- Publication number 20230303696
- Publication date Sep 28, 2023
- Regeneron Pharmaceuticals, Inc.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS OF USE THEREOF
- Publication number 20230292721
- Publication date Sep 21, 2023
- Regeneron Pharmaceuticals, Inc.
- Dietmar Herndler-Brandstetter
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
Bispecific Anti-MUC16 x Anti-CD28 Antibodies and Uses Thereof
- Publication number 20230279113
- Publication date Sep 7, 2023
- Regeneron Pharmaceuticals, Inc.
- Andrew J. Murphy
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bispecific Anti-PSMA x Anti-CD28 Antibodies and Uses Thereof
- Publication number 20230272078
- Publication date Aug 31, 2023
- Regeneron Pharmaceuticals, Inc.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING AN ALLERGY WITH ALLERGEN-SPECIFIC MONOCLONAL AN...
- Publication number 20230203141
- Publication date Jun 29, 2023
- Regeneron Pharmaceuticals, Inc.
- Jamie M. Orengo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bispecific Anti-CD28 X Anti-CD22 Antibodies and Uses Thereof
- Publication number 20230174652
- Publication date Jun 8, 2023
- Regeneron Pharmaceuticals, Inc.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-SARS-CoV-2-Spike Glycoprotein Antibodies and Antigen-Binding F...
- Publication number 20230125469
- Publication date Apr 27, 2023
- Regeneron Pharmaceuticals, Inc.
- Alina BAUM
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-SARS-CoV-2-Spike Glycoprotein Antibodies and Antigen-Binding F...
- Publication number 20220356230
- Publication date Nov 10, 2022
- Regeneron Pharmaceuticals, Inc.
- Robert Babb
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of a VEGF Antagonist to Treat Angiogenic Eye Disorders
- Publication number 20220273764
- Publication date Sep 1, 2022
- Regeneron Pharmaceuticals, Inc.
- George D. YANCOPOULOS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Genetically Modified Mice and Engraftment
- Publication number 20220000084
- Publication date Jan 6, 2022
- Regeneron Pharmaceuticals, Inc.
- Sean Stevens
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
Genetically Modified Non-Human Animals And Methods Of Use Thereof
- Publication number 20210368752
- Publication date Dec 2, 2021
- Regeneron Pharmaceuticals, Inc.
- Richard Flavell
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS
- Publication number 20210308216
- Publication date Oct 7, 2021
- Regeneron Pharmaceuticals, Inc.
- George YANCOPOULOS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS
- Publication number 20210308217
- Publication date Oct 7, 2021
- Regeneron Pharmaceuticals, Inc.
- George YANCOPOULOS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

George D. Yancopoulos

Person

Patents Grantslast 30 patents

High affinity human antibodies to human IL-4 receptor

Humanized M-CSF mice

Genetically modified non-human animals and methods of use thereof

Targeted modification of rat genome

Use of a VEGF antagonist to treat angiogenic eye disorders

Use of a VEGF antagonist to treat angiogenic eye disorders

Combination of IL-4/IL-13 pathway inhibitors and plasma cell ablati...

EGFR × CD28 multispecific antibodies

Methods for treating inflammatory conditions of the airway or lungs...

Methods and compositions for the targeted modification of a genome

Genetically modified non-human animals and methods of use thereof

Use of a VEGF antagonist to treat angiogenic eye disorders

Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding f...

Use of a VEGF antagonist to treat angiogenic eye disorders

Methods and compositions for targeted genetic modification using pa...

Genetically modified non-human animals and methods of use thereof

Use of a VEGF antagonist to treat angiogenic eye disorders

Bispecific anti-PSMA X anti-CD28 antibodies and uses thereof

Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereof

Bispecific anti-CD28 × anti-CD22 antibodies and uses thereof

Method of treating an allergy with allergen-specific monoclonal ant...

Use of a VEGF antagonist to treat angiogenic eye disorders

Genetically modified mice and engraftment

Genetically modified non-human animals and methods of use thereof

Methods of modifying genes in eukaryotic cells

Targeted modification of rat genome

Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding f...

Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding f...

Diagnostic tests and methods for assessing safety, efficacy or outc...

Use of a VEGF antagonist to treat angiogenic eye disorders

Patents Applicationslast 30 patents

ANTIBODY RESISTANT MODIFIED RECEPTORS TO ENHANCE CELL-BASED THERAPIES

COMBINATION OF IL-4/IL-13 PATHWAY INHIBITORS AND PLASMA CELL ABALAT...

METHODS FOR OBTAINING ANTIBODY MOLECULES WITH HIGH AFFINITY

METHODS AND COMPOSITIONS FOR INSERTION OF ANTIBODY CODING SEQUENCES...

T CELL ACTIVATORS AND METHODS OF USE THEREOF

INDUCED NK CELLS RESPONSIVE TO CD3/TAA BISPECIFIC ANTIBODIES

METHODS OF TREATING INFLAMMATORY CONDITIONS

ANTI-C5 ANTIBODY/C5 IRNA CO-FORMULATIONS AND COMBINATION THERAPIES

Treatment Of Kidney Diseases With A Combination of Angiopoietin Lik...

Use of a VEGF Antagonist to Treat Angiogenic Eye Disorders

GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS FOR THE TARGETED MODIFICATION OF A GENOME

Anti-SARS-CoV-2-Spike Glycoprotein Antibodies and Antigen-Binding F...

Anti-SARS-CoV-2-Spike Glycoprotein Antibodies and Antigen-Binding F...

METHODS AND COMPOSITIONS FOR TARGETED GENETIC MODIFICATION USING PA...

EGFR x CD28 MULTISPECIFIC ANTIBODIES

ANTI-ACTIVIN A ANTIBODIES AND USES THEREOF

Bispecific Anti-PSMA x Anti-CD28 Antibodies and Uses Thereof

GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS OF USE THEREOF

Bispecific Anti-MUC16 x Anti-CD28 Antibodies and Uses Thereof

Bispecific Anti-PSMA x Anti-CD28 Antibodies and Uses Thereof

METHODS OF TREATING AN ALLERGY WITH ALLERGEN-SPECIFIC MONOCLONAL AN...

Bispecific Anti-CD28 X Anti-CD22 Antibodies and Uses Thereof

Anti-SARS-CoV-2-Spike Glycoprotein Antibodies and Antigen-Binding F...

Anti-SARS-CoV-2-Spike Glycoprotein Antibodies and Antigen-Binding F...

Use of a VEGF Antagonist to Treat Angiogenic Eye Disorders

Genetically Modified Mice and Engraftment

Genetically Modified Non-Human Animals And Methods Of Use Thereof

USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS

USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS